187 related articles for article (PubMed ID: 23512063)
1. Computed tomography screening for lung cancer.
Boiselle PM
JAMA; 2013 Mar; 309(11):1163-70. PubMed ID: 23512063
[TBL] [Abstract][Full Text] [Related]
2. Reduced lung-cancer mortality with low-dose computed tomographic screening.
; Aberle DR; Adams AM; Berg CD; Black WC; Clapp JD; Fagerstrom RM; Gareen IF; Gatsonis C; Marcus PM; Sicks JD
N Engl J Med; 2011 Aug; 365(5):395-409. PubMed ID: 21714641
[TBL] [Abstract][Full Text] [Related]
3. Targeting of low-dose CT screening according to the risk of lung-cancer death.
Kovalchik SA; Tammemagi M; Berg CD; Caporaso NE; Riley TL; Korch M; Silvestri GA; Chaturvedi AK; Katki HA
N Engl J Med; 2013 Jul; 369(3):245-254. PubMed ID: 23863051
[TBL] [Abstract][Full Text] [Related]
4. CT quality assurance in the lung screening study component of the National Lung Screening Trial: implications for multicenter imaging trials.
Gierada DS; Garg K; Nath H; Strollo DC; Fagerstrom RM; Ford MB
AJR Am J Roentgenol; 2009 Aug; 193(2):419-24. PubMed ID: 19620438
[TBL] [Abstract][Full Text] [Related]
5. A feasibility study examining the effect on lung cancer diagnosis of offering a chest X-ray to higher-risk patients with chest symptoms: protocol for a randomized controlled trial.
Hurt CN; Roberts K; Rogers TK; Griffiths GO; Hood K; Prout H; Nelson A; Fitzgibbon J; Barham A; Thomas-Jones E; Edwards RT; Yeo ST; Hamilton W; Tod A; Neal RD
Trials; 2013 Nov; 14():405. PubMed ID: 24279296
[TBL] [Abstract][Full Text] [Related]
6. UKLS trial: looking beyond negative results.
Darrason M; Grolleau E; De Bermont J; Couraud S
Lancet Reg Health Eur; 2021 Nov; 10():100184. PubMed ID: 34806064
[No Abstract] [Full Text] [Related]
7. Underestimating the lung cancer mortality reductions produced by low-dose CT screening.
Hanley JA; Deck W; Kochoedo M
Lancet Reg Health Eur; 2021 Dec; 11():100256. PubMed ID: 34778862
[No Abstract] [Full Text] [Related]
8. Understanding the lung cancer mortality reductions produced by low-dose CT screening.
Furukawa Y
Lancet Reg Health Eur; 2021 Dec; 11():100255. PubMed ID: 34778861
[No Abstract] [Full Text] [Related]
9. Peeling back the onion: addressing nuances of CT screening for lung cancer.
Detterbeck FC
J Thorac Dis; 2018 Feb; 10(2):585-588. PubMed ID: 29608192
[No Abstract] [Full Text] [Related]
10. Risk models to select high risk candidates for lung cancer screening.
Schabath MB
Ann Transl Med; 2018 Feb; 6(3):65. PubMed ID: 29611557
[No Abstract] [Full Text] [Related]
11. Results of initial low-dose computed tomographic screening for lung cancer.
; Church TR; Black WC; Aberle DR; Berg CD; Clingan KL; Duan F; Fagerstrom RM; Gareen IF; Gierada DS; Jones GC; Mahon I; Marcus PM; Sicks JD; Jain A; Baum S
N Engl J Med; 2013 May; 368(21):1980-91. PubMed ID: 23697514
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of CT screening in the National Lung Screening Trial.
Black WC; Gareen IF; Soneji SS; Sicks JD; Keeler EB; Aberle DR; Naeim A; Church TR; Silvestri GA; Gorelick J; Gatsonis C;
N Engl J Med; 2014 Nov; 371(19):1793-802. PubMed ID: 25372087
[TBL] [Abstract][Full Text] [Related]
13. Screening for lung cancer.
Manser R; Lethaby A; Irving LB; Stone C; Byrnes G; Abramson MJ; Campbell D
Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD001991. PubMed ID: 23794187
[TBL] [Abstract][Full Text] [Related]
14. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers.
Horeweg N; Scholten ET; de Jong PA; van der Aalst CM; Weenink C; Lammers JW; Nackaerts K; Vliegenthart R; ten Haaf K; Yousaf-Khan UA; Heuvelmans MA; Thunnissen E; Oudkerk M; Mali W; de Koning HJ
Lancet Oncol; 2014 Nov; 15(12):1342-50. PubMed ID: 25282284
[TBL] [Abstract][Full Text] [Related]
15. Overdiagnosis in low-dose computed tomography screening for lung cancer.
Patz EF; Pinsky P; Gatsonis C; Sicks JD; Kramer BS; Tammemägi MC; Chiles C; Black WC; Aberle DR;
JAMA Intern Med; 2014 Feb; 174(2):269-74. PubMed ID: 24322569
[TBL] [Abstract][Full Text] [Related]
16. Low-dose computed tomography screening for lung cancer: how strong is the evidence?
Woolf SH; Harris RP; Campos-Outcalt D
JAMA Intern Med; 2014 Dec; 174(12):2019-22. PubMed ID: 25317533
[TBL] [Abstract][Full Text] [Related]
17. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement.
Moyer VA;
Ann Intern Med; 2014 Mar; 160(5):330-8. PubMed ID: 24378917
[TBL] [Abstract][Full Text] [Related]
18. Lung cancer screening: advantages, controversies, and applications.
Nanavaty P; Alvarez MS; Alberts WM
Cancer Control; 2014 Jan; 21(1):9-14. PubMed ID: 24357736
[TBL] [Abstract][Full Text] [Related]
19. Lung cancer screening.
Tanoue LT; Tanner NT; Gould MK; Silvestri GA
Am J Respir Crit Care Med; 2015 Jan; 191(1):19-33. PubMed ID: 25369325
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
